In particular, impairment of the eNOS response to ANP has been observed in SHR as compared to normotensive WKY, thus suggesting that dysfunctions in the NPR-C signaling pathway, which leads to the reduced NO availability, may contribute to the maintenance of hypertension in SHR [13]. The gene discussed is NOS3; the disease is hypertensive disorder.